Jacopo Mariotti

11PUBLICATIONS
13CO-AUTHORS
Haematological tumoursTransplantation immunologyHaematologyEpidemiological modellingRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Mar 28, 2026
Reduced relapse rate and improved GVHD/relapse free survival (GRFS) with pharmacokinetics-guided busulfan conditioning regimen for allogeneic stem cell transplantation in adult patients with myeloid hematologic malignancies.

Jacopo Mariotti, Chiara De Philippis, Simona De Gregori

|Sep 01, 2025
Reduced incidence of relapse after checkpoint inhibitors relative to brentuximab vedotin as salvage therapy before allogeneic stem cell transplantation for refractory/relapsed Hodgkin lymphoma: A retrospective analysis.

Jacopo Mariotti, Chiara Pinton, Laura Giordano

|Oct 04, 2024
Impact of daratumumab on collection and engraftment in multiple myeloma patients undergoing hematopoietic stem cell mobilization with G-CSF plus on-demand plerixafor.

Giuseppe Bertuglia, Bruno Garibaldi, Andrea Casson

|Nov 22, 2022
EASIX predicts non-relapse mortality after haploidentical transplantation with post-transplant cyclophosphamide.

Jacopo Mariotti, Filippo Magri, Laura Giordano

|Jul 15, 2021
Cytokine release syndrome after haploidentical hematopoietic cell transplantation: an international multicenter analysis.

Ramzi Abboud, Fei Wan, Jacopo Mariotti

|Nov 09, 2019
Pretransplant active disease status and HLA class II mismatching are associated with increased incidence and severity of cytokine release syndrome after haploidentical transplantation with posttransplant cyclophosphamide.

Jacopo Mariotti, Daniela Taurino, Fabrizio Marino

Pageof 2

Frequent Collaborators

3 joint publications

Chiara De Philippis

2 joint publications

Luca Castagna

2 joint publications

Christian Chabannon

2 joint publications

Didier Blaise